Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsRespiratory

ICU · Respiratory

Extracorporeal CO2 removal (ECCO2R) in ICU

Also known as ECCO2R · Extracorporeal carbon dioxide removal · CO2 removal · Low-flow ECMO · Respiratory dialysis

Extracorporeal CO2 removal (ECCO2R): low-flow extracorporeal circuit that removes CO2 WITHOUT substantially improving oxygenation (unlike VV-ECMO). Indications: (1) HYPERCAPNIC respiratory failure (COPD exacerbation) where NIV is at risk of failing — ECCO2R removes CO2 → may avoid intubation. (2) FACILITATE ultra-protective ventilation in ARDS (remove CO2 while using very low tidal volumes down to ~4 mL/kg → less volutrauma). (3) BRIDGE to lung transplant. ADVANTAGE over VV-ECMO: lower flow (roughly 0.4-1.5 L/min) → smaller cannulae → less invasive. LIMITATION: minimal oxygenation (cannot treat severe hypoxaemia — need VV-ECMO for that). EVIDENCE: feasibility shown in SUPERNOVA and CRRT-platform cohorts, but the REST randomized trial found no 90-day mortality benefit — ECCO2R remains investigational, specialist-centre, carefully selected patients.

medium30 referencesUpdated 20 Aug 202621 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • ECCO2R removes CO2 — NOT effective for severe hypoxaemia (need VV-ECMO for hypoxaemia)
  • ECCO2R can FACILITATE ultra-protective ventilation (Vt down to ~4 mL/kg) in ARDS — reduces volutrauma
  • Lower flow than VV-ECMO → smaller cannulae, less invasive — but the REST trial showed no mortality benefit
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • ECCO2R removes CO2 — NOT effective for severe hypoxaemia (need VV-ECMO for hypoxaemia)
  • ECCO2R can FACILITATE ultra-protective ventilation (Vt down to ~4 mL/kg) in ARDS — reduces volutrauma
  • Lower flow than VV-ECMO → smaller cannulae, less invasive — but the REST trial showed no mortality benefit
[4] [25]
In one line

ECCO2R is a low-flow extracorporeal circuit that removes CO2 from venous blood without substantially improving oxygenation — "respiratory dialysis for CO2." Modern systems run at roughly 0.4–1.5 L/min of blood flow (a fraction of what VV-ECMO needs for oxygenation), with smaller cannulae and simpler devices. Three indications dominate: COPD exacerbation at risk of failing NIV (intubation avoided in 56–90% of carefully selected patients), ultra-protective ventilation in ARDS (Vt down to 4 mL/kg achieved in ~4 of 5 SUPERNOVA patients by 24 h; 3 mL/kg or less is feasible in only a minority), and awake bridge to lung transplantation. It cannot treat severe hypoxaemia — and the evidence remains investigational: the REST randomized trial (412 patients, stopped early for futility) found no 90-day mortality benefit and fewer ventilator-free days with ECCO2R.[4][25][9][28][24]

Meet the patient

A 68-year-old man with severe COPD (FEV₁ 35 per cent predicted) is admitted with an infective exacerbation. He is on optimal NIV — IPAP 18, EPAP 6, FiO₂ 0.4 — but his ABG is pH 7.22, PaCO₂ 78 mmHg, PaO₂ 64 mmHg, he is RR 32 and somnolent. The team is reaching for the intubation trolley. The registrar's question — "is there a middle road between NIV and intubation?" — is the question this page answers.[1][7]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References30ShowHide
  1. [1]Braune S, Kluge S ECCO(2)R in COPD exacerbation: response to comments by Del Sorbo et al. Intensive care medicine, 2016.PMID 27586995
  2. [2]Bein T, Aubron C, Papazian L Focus on ECMO and ECCO(2)R in ARDS patients. Intensive care medicine, 2017.PMID 28717835
  3. [3]Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO(2) removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive care medicine, 2019.PMID 30790030
  4. [4]Staudinger T Update on extracorporeal carbon dioxide removal: a comprehensive review on principles, indications, efficiency, and complications. Perfusion, 2020.PMID 32156179
  5. [5]Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO(2) removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive care medicine, 2019.PMID 30790030
  6. [7]Del Sorbo L, Pisani L, Filippini C, et al. Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Critical care medicine, 2015.PMID 25230375
  7. [8]Burki NK, Mani RK, Herth FJF, et al. A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest, 2013.PMID 23460154
  8. [9]Combes A, Fanelli V, Pham T, Ranieri VM Feasibility and safety of extracorporeal CO(2) removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive care medicine, 2019.PMID 30790030
  9. [10]Goligher EC, Combes A, Brodie D, et al. Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design. Intensive care medicine, 2019.PMID 31432216
  10. [11]Schmidt M, Herisse M, Ponthus C, et al. Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Critical care, 2018.PMID 29743094
  11. [12]Morelli A, Del Sorbo L, Pesenti A, Ranieri VM, Fan E Extracorporeal carbon dioxide removal (ECCO(2)R) in patients with acute respiratory failure. Intensive care medicine, 2017.PMID 28132075
  12. [13]Boyle AJ, Sklar M, McNamee JJ, et al. Extracorporeal carbon dioxide removal for lowering the risk of mechanical ventilation: research questions and clinical potential for the future. Lancet Respiratory Medicine, 2018.PMID 30484429
  13. [14]Terragni P, Maiolo G, Ranieri VM Role and potentials of low-flow CO(2) removal system in mechanical ventilation. Current opinion in critical care, 2012.PMID 22186219
  14. [15]Strassmann S, Mertens MC, Bickenbach J, et al. Impact of sweep gas flow on extracorporeal CO(2) removal (ECCO(2)R). Intensive care medicine experimental, 2019.PMID 30911910
  15. [16]Cummins C, McFadyen A, Rafferty I, Poenaru D, Kinsella J A United Kingdom Register study of in-hospital outcomes of patients receiving extracorporeal carbon dioxide removal. Journal of intensive care society, 2018.PMID 29796067
  16. [17]Fitzgerald M, Millar J, Blackwood B, et al. Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Critical care, 2014.PMID 25033302
  17. [18]Zimmermann M, Bein T, Arlt M, et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Critical care, 2009.PMID 19183475
  18. [19]Muller T, Lubnow M, Philipp A, et al. Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. European respiratory journal, 2009.PMID 19010979
  19. [20]Bein T, Zimmermann M, Hergeth K, et al. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO journal, 2011.PMID 21427564
  20. [21]Worku E, Okeke C, Patel R, Goyal R, Henry M Venovenous extracorporeal CO(2) removal to support ultraprotective ventilation in moderate-severe acute respiratory distress syndrome: a systematic review and meta-analysis of the literature. Perfusion, 2023.PMID 35656595
  21. [22]Karagiannidis C, Brodie D, Strassmann S, et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive care medicine, 2016.PMID 26942446
  22. [23]Westhoff M, Schonhofer B, Neumann P, et al. [Severe hypercapnic respiratory failure in acute exacerbation of COPD: significance of ventilation and extracorporal CO2 removal]. Deutsche medizinische Wochenschrift, 2016.PMID 27903026
  23. [6]Kryvenko V, Husain-Syed F, Schnell E, et al. Minimally invasive extracorporeal CO(2) removal in hypercapnic respiratory failure: a prospective observational study. Critical care (London, England), 2026.PMID 42057044
  24. [24]McNamee JJ, Gillies MA, Barrett NA, et al. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA, 2021.PMID 34463700
  25. [25]Lamas T, Fernandes SM, Vasques F, et al. Recent Advances and Future Directions in Extracorporeal Carbon Dioxide Removal. Journal of clinical medicine, 2024.PMID 39797096
  26. [26]Karagiannidis C, Strassmann S, Brodie D, et al. Impact of membrane lung surface area and blood flow on extracorporeal CO(2) removal during severe respiratory acidosis. Intensive care medicine experimental, 2017.PMID 28766276
  27. [27]Pooth JS, Förster JK, Benk C, et al. Impact of Cannulation Strategy and Extracorporeal Blood Flow on Recirculation During Veno-Venous Extracorporeal Membrane Oxygenation. Artificial organs, 2025.PMID 39868656
  28. [28]Monet C, Renault T, Aarab Y, et al. Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCO(2)R) in acute respiratory failure patients. Critical care (London, England), 2024.PMID 39731126
  29. [29]Combes A, Levy B, Tapponnier R, et al. A prospective clinical evaluation of new ECCO2R technology in mild to moderate ARDS patients: assessing ultra-lung-protective ventilation with PRISMALUNG. Critical care (London, England), 2026.PMID 41495763
  30. [30]Terragni PP, Birocco A, Faggiano C, Ranieri VM Extracorporeal CO2 removal. Contributions to nephrology, 2010.PMID 20427969

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAtypical pneumonias in ICU: Legionella, Mycoplasma, ChlamydiaRespiratoryNextFlexible bronchoscopy in the intensive care unitRespiratory